Chandra Mani Kafle

I am a biomedical researcher.

I study the functional and molecular implications of cancer-associated mutations in a critical tumor suppressor. I use biochemical and molecular biology approaches to investigate the molecular landscape of common hotspot mutations seen in endometrial cancers.

Prior to this, I studied Adenovirus-induced cellular DNA damage response, cell cycle, and DNA replication. The findings from my work show that Ad-induction of DDR is necessary for the activation of G2/M checkpoint kinases in E4-mutant infected cells. We also showed that E4-mutant infected cells are arrested at a phase characterized by either 4N or >4N DNA content while preventing cells from going through mitosis.

I also investigated the efficacy of artemisinin–lumefantrine–based combination therapy (ACT) for the treatment of Plasmodium falciparum malaria in Nepal. In this multi-institutional collaborative study, we conducted a therapeutic efficacy assessment among falciparum malaria patients treated with ACT in regions of Nepal characterized by high mobility of migrant workers.

I occasionally write for local publications and take photographs during my hikes.